By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Selexis SA 

177 Post Street, Suite 900

San Francisco  California  94108  U.S.A.
Phone: 415-273-5141 Fax: 415-421-5510


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Selexis SA And OSE Immunotherapeutics Collaborate To Advance Development Of Immunotherapies For Cancer And Autoimmune Diseases 11/16/2016 10:36:03 AM
Selexis SA And OSE Immunotherapeutics Collaborate To Advance Development Of Immunotherapies For Cancer And Autoimmune Diseases 11/15/2016 11:29:07 AM
Selexis SA And Xencor Enter Strategic Agreement, Strengthening Existing Relationship For Multi-Specific Antibody Cell Line Development 11/3/2016 11:29:22 AM
Selexis SA And Xencor Enter Strategic Agreement, Strengthening Existing Relationship For Multi-Specific Antibody Cell Line Development 11/3/2016 9:02:10 AM
Selexis SA Inks Commercial Cell Line License Agreement With Immunext For Anti-CD40L Antibody Being Developed For Treatment Of Chronic Autoimmune Disorders 10/25/2016 10:09:30 AM
Selexis SA Release: Protein Expression Challenges? Meet Us At PEGS-Europe And BIO-Europe 10/10/2016 11:25:11 AM
Selexis SA Announces Participation At Two Upcoming Industry Conferences 10/10/2016 9:16:34 AM
Selexis SA Chairman and CEO Dr. Igor Fisch Receives Prestigious Award For Excellence In Leadership From BioProcess International 10/6/2016 11:11:57 AM
Selexis SA And IAVI Expand Collaboration To Advance Multiple HIV Vaccine Candidates Toward Clinical Testing 9/22/2016 11:12:16 AM
Selexis SA And International AIDS Vaccine Initiative Expand Collaboration to Advance Multiple HIV Vaccine Candidates Toward Clinical Testing 9/22/2016 11:11:55 AM
123456
//-->